NCT01262794View on ClinicalTrials.gov

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

CDP6038

100 mg/mL solution for injection, single dose

BIOLOGICAL

Placebo

0.9% sodium chloride for injection Single-dose

Trial Locations (1)

Unknown

Guildford

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY